Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Highlight Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 81
Average round size
info
The average size of a deal this fund participated in
$34M
Portfolio companies 66
Rounds per year 10.12
Lead investments 20
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.19
Exits 4
Key employees 6

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Biopharma
Summary

Highlight Capital appeared to be the VC, which was created in 2014. The main department of described VC is located in the Nanjin. The company was established in Asia in China.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Highlight Capital, startups are often financed by WI Harper Group, Qiming Venture Partners, Prometheus Capital. The meaningful sponsors for the fund in investment in the same round are Wu Capital, V Star Capital, Sequoia Capital China. In the next rounds fund is usually obtained by Aphelion Capital, Wu Capital, SDIC Fund Management.

The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Chemclin, Quyi Network, Imago BioSciences. We can highlight the next thriving fund investment areas, such as Biotechnology, Biopharma. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 19 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Highlight Capital performs on 26 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2013. The fund is generally included in 2-6 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Highlight Capital:
Typical Co-investors
Highlight Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Highlight Capital:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Yaotan Pharmaceutical

$30M29 Mar 2022 Shanghai, Shanghai, China

Medilink Therapeutics

Biotechnology
Genetics
Therapeutics
$70M14 Mar 2022 Gusu District, Jiangsu, China

Bichen Pharmaceutical

Biopharma
Medical
Pharmaceutical
$30M04 Jan 2022 Shanghai, Shanghai, China

SparX Group

Biopharma
Biotechnology
Health Care
$30M31 Dec 2021 -

Thousand Oaks Biopharmaceuticals

Biopharma
Biotechnology
Health Care
$231M28 Dec 2021 China, Guangdong Province, China

ColorTech Bio

$23M20 Dec 2021 -

Qinghui Liannuo

Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
$15M22 Nov 2021 Beijing, Beijing, China

Vision X

Health Care
29 Sep 2021 Zhuhai, Guangdong, China

Inmagene Biopharmaceuticals

Biopharma
Biotechnology
Health Care
$100M01 Jun 2021 Zhangdian District, Shandong, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Highlight Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: